BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21453641)

  • 1. Treatment of a nasal vascular malformation in a patient with Osler-Weber-Rendu syndrome via percutaneous N-butyl 2-cyanoacrylate embolization: case report and review of the literature.
    Chowdhry SA; Ponsky DC; Hsu DP
    J Otolaryngol Head Neck Surg; 2011 Apr; 40(2):E11-4. PubMed ID: 21453641
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous embolization for control of nasal blood circulation.
    Parnes LS; Heeneman H; Vinuela F
    Laryngoscope; 1987 Nov; 97(11):1312-5. PubMed ID: 2823032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
    Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
    Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience].
    Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J
    Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
    Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
    Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osler-Weber-Rendu syndrome.
    Mani BI; Rubel AR; Chauhdary WA; Bashir A; Soe ZN; Javed N; Sharif SMA; Hla Aye MT; Chong VH
    QJM; 2020 Aug; 113(8):586-587. PubMed ID: 32170936
    [No Abstract]   [Full Text] [Related]  

  • 7. N-butyl-2-cyanoacrylate (NBCA) tissue adhesive as a haemostatic agent in a venous malformation of the mandible.
    Idle MR; Monaghan AM; Lamin SM; Grant SW
    Br J Oral Maxillofac Surg; 2013 Sep; 51(6):565-7. PubMed ID: 23182417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
    Strother CM; Newton TH
    Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of superselective embolization of the maxillary artery in treatment of bleedings in the Rendu-Osler-Weber syndrome].
    Kantor I; Winiarski M; Jurkiewicz D; Osiecki M; Brzozowski K
    Otolaryngol Pol; 2005; 59(2):215-7. PubMed ID: 16095090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Embolization of branches of the external carotid artery in nosebleeds complicating Rendu-Osler-Weber disease].
    Nekipelov EF; Serbinenko FA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):23-33. PubMed ID: 6624354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Rendu-Osler-Weber disease--is embolization beneficial?
    Weisberg JJ
    Arch Otolaryngol; 1976 Jun; 102(6):385. PubMed ID: 1275812
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
    Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel treatment for patients with hereditary haemorrhagic telangiectasia.
    Farnan TB; Gallagher G; Scally CM
    J Laryngol Otol; 2002 Oct; 116(10):849-50. PubMed ID: 12437844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osler-Rendu-Weber syndrome: congenital arteriovenous intrapulmonary fistula treated using a percutaneous Amplatzer plug.
    Conti V; Fiorucci F; Serpilli M; Patrizi A; Paone G; Neri P; Giannunzio G; Pirozzo MG; Fiorucci C; Lucantoni G
    Eur Rev Med Pharmacol Sci; 2008; 12(3):213-6. PubMed ID: 18700694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
    Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary haemorrhagic telangiectasia.
    Sharathkumar AA; Shapiro A
    Haemophilia; 2008 Nov; 14(6):1269-80. PubMed ID: 19141168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
    Weissman JL; Jungreis CA; Johnson JT
    Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Injections of fibrin glue in severe epistaxis and Rendu-Osler disease].
    Martin H; Martin C
    Ann Otolaryngol Chir Cervicofac; 1984; 101(7):561-3. PubMed ID: 6334470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-butyl cyanoacrylate proved beneficial to avoid a nontarget embolization of the ophthalmic artery in endovascular management of epistaxis. A neurointerventional report and literature review.
    Shuster A; Gunnarsson T; Klurfan P; Larrazabal R
    Interv Neuroradiol; 2011 Mar; 17(1):17-21. PubMed ID: 21561554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.